Global Cord Blood

Historical price data

Global Cord Blood Corporation is a dominant player in the Chinese cord blood banking industry, operating through its subsidiaries in key regions like Beijing, Guangdong, and Zhejiang. The company's core business is the preservation of hematopoietic stem cells from umbilical cord blood, which are used in transplant medicine for treating various blood and immune system disorders. It has established a significant market presence and a large stored inventory, positioning it as a critical infrastructure provider in the regenerative medicine sector in China. The company faces a dynamic regulatory environment and competition but benefits from first-mover advantages and established operational scale.

Cord blood banking service platform specializing in the collection, processing, testing, and long-term cryogenic storage of hematopoietic stem cells from umbilical cord blood for family use.

Primary competitors are other licensed cord blood banks in China, such as China Cord Blood Corporation. Competition is regionalized due to licensing. Differentiation is based on service quality, reputation, and the security provided by being a publicly listed entity with established operations.